Nautilus Biotechnology Appoints Nick Nelson as Chief Business Officer

SAN CARLOS, Calif. & SEATTLE--(BUSINESS WIRE)--Nautilus Biotechnology, a company pioneering a high-throughput, low-cost platform for quantifying the human proteome, today announced the appointment of Nick Nelson as Chief Business Officer. Joining the company on the heels of Nautilus’ recent $76 million series B funding, Mr. Nelson will drive the design and execution of the company’s business development activities, including partnerships, alliances, and community engagement. “Anyone who’s worke

Click to view original post